Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Aarti Pharmalabs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543748NSE Symbol: AARTIPHARMP/E(TTM):31.34
ISIN Demat:INE0LRU01027Div & Yield %:0.56EPS(TTM):28.39
Book Value(Rs):203.4396162Market Cap ( Cr.):8064.22Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :     
Sales Turnover 1502.131511.25941.020.000.00
Excise Duty0.000.000.000.000.00
Net Sales1502.131511.25941.020.000.00
Other Income 11.011.282.510.000.00
Stock Adjustments 23.3691.2232.540.000.00
Total Income1536.501603.75976.070.000.00
EXPENDITURE :     
Raw Materials 775.33909.15484.200.000.00
Power & Fuel Cost82.9274.2243.430.000.00
Employee Cost 120.15113.9279.980.000.00
Other Manufacturing Expenses 100.9491.11164.690.000.00
Selling and Administration Expenses 76.3482.9321.460.000.02
Miscellaneous Expenses 23.6522.800.010.000.00
Less: Pre-operative Expenses Capitalised0.000.000.000.000.00
Total Expenditure1179.331294.14793.780.000.02
Operating Profit357.16309.62182.300.00-0.02
Interest 16.6320.4911.340.000.00
Gross Profit340.53289.13170.960.00-0.02
Depreciation66.0155.7737.230.000.00
Profit Before Tax274.52233.36133.730.00-0.02
Tax46.0652.1322.500.000.00
Fringe Benefit tax0.000.000.000.000.00
Deferred Tax27.829.504.500.000.00
Reported Net Profit200.65171.73106.730.00-0.02
Extraordinary Items 0.000.000.030.000.00
Adjusted Net Profit200.65171.73106.700.00-0.02
Adjst. below Net Profit 0.000.00599.240.000.00
P & L Balance brought forward859.55705.95-0.02-0.020.00
Statutory Appropriations 0.000.000.000.000.00
Appropriations 18.1318.130.000.000.00
P & L Balance carried down1042.07859.55705.95-0.02-0.02
Dividend18.1318.130.000.000.00
Preference Dividend0.000.000.000.000.00
Equity Dividend %60.0040.000.000.000.00
Earnings Per Share-Unit Curr22.1418.954269.05-0.18-0.75
Earnings Per Share(Adj)-Unit Curr22.1418.95NANANA
Book Value-Unit Curr178.92158.7449558.529.079.25